SCL Science Statistics
Total Valuation
SCL Science has a market cap or net worth of KRW 84.96 billion. The enterprise value is 96.88 billion.
Market Cap | 84.96B |
Enterprise Value | 96.88B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SCL Science has 8.48 million shares outstanding. The number of shares has increased by 9.04% in one year.
Current Share Class | 8.48M |
Shares Outstanding | 8.48M |
Shares Change (YoY) | +9.04% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | 5.32% |
Owned by Institutions (%) | n/a |
Float | 4.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 14.47 |
PB Ratio | 3.21 |
P/TBV Ratio | 5.59 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -20.48 |
EV / Sales | 16.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -11.95 |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.88.
Current Ratio | 2.40 |
Quick Ratio | 2.06 |
Debt / Equity | 0.88 |
Debt / EBITDA | n/a |
Debt / FCF | -2.86 |
Interest Coverage | -10.04 |
Financial Efficiency
Return on equity (ROE) is -21.11% and return on invested capital (ROIC) is -7.35%.
Return on Equity (ROE) | -21.11% |
Return on Assets (ROA) | -6.39% |
Return on Invested Capital (ROIC) | -7.35% |
Return on Capital Employed (ROCE) | -9.34% |
Revenue Per Employee | 94.69M |
Profits Per Employee | -76.29M |
Employee Count | 62 |
Asset Turnover | 0.13 |
Inventory Turnover | 5.81 |
Taxes
In the past 12 months, SCL Science has paid 681,990 in taxes.
Income Tax | 681,990 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.95% in the last 52 weeks. The beta is 0.45, so SCL Science's price volatility has been lower than the market average.
Beta (5Y) | 0.45 |
52-Week Price Change | -8.95% |
50-Day Moving Average | 8,177.40 |
200-Day Moving Average | 8,672.60 |
Relative Strength Index (RSI) | 84.50 |
Average Volume (20 Days) | 132,069 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SCL Science had revenue of KRW 5.87 billion and -4.73 billion in losses. Loss per share was -650.65.
Revenue | 5.87B |
Gross Profit | 1.51B |
Operating Income | -4.47B |
Pretax Income | -4.73B |
Net Income | -4.73B |
EBITDA | -3.19B |
EBIT | -4.47B |
Loss Per Share | -650.65 |
Balance Sheet
The company has 11.37 billion in cash and 23.21 billion in debt, giving a net cash position of -11.84 billion or -1,396.66 per share.
Cash & Cash Equivalents | 11.37B |
Total Debt | 23.21B |
Net Cash | -11.84B |
Net Cash Per Share | -1,396.66 |
Equity (Book Value) | 26.50B |
Book Value Per Share | 3,115.92 |
Working Capital | 13.65B |
Cash Flow
In the last 12 months, operating cash flow was -7.79 billion and capital expenditures -320.08 million, giving a free cash flow of -8.11 billion.
Operating Cash Flow | -7.79B |
Capital Expenditures | -320.08M |
Free Cash Flow | -8.11B |
FCF Per Share | -956.19 |
Margins
Gross margin is 25.77%, with operating and profit margins of -76.07% and -80.56%.
Gross Margin | 25.77% |
Operating Margin | -76.07% |
Pretax Margin | -80.55% |
Profit Margin | -80.56% |
EBITDA Margin | -54.29% |
EBIT Margin | -76.07% |
FCF Margin | n/a |
Dividends & Yields
SCL Science does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.04% |
Shareholder Yield | n/a |
Earnings Yield | -5.57% |
FCF Yield | -9.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SCL Science has an Altman Z-Score of 0.4 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.4 |
Piotroski F-Score | 1 |